Pay in 4 interest-free payments of $13.75 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action in vivo
Azacytidine
Inhibition of cathepsin L thus holds promise for therapeutic intervention for both SARS-CoV and Ebola virus infection
Epub 2013 Feb 1
Journal of Medicinal Chemistry (2020)
Valrubicin - CAS# 56124-62-0 123 a potent inhibitor of mitogen-activatedValrubicin, CAS No. 56124 62 0, is a semisynthetic derivative of the antineoplastic anthracycline antibiotic doxorubicin. With a mechanism of action that appears to differ from doxorubicin, valrubicin is converted intracytoplasmically into N trifluoroacetyladriamycin, which interacts with topoisomerase II, stabilizing the complex between the enzyme and DNA; consequently, DNA replication and repair and RNA and protein synthesis are inhibited and the
US$ 62.00
US$ 10.00
US$ 360.50
US$ 34.00
US$ 12.00
US$ 1237.50
US$ 52.00
US$ 16.00
US$ 139.00
US$ 178.50
US$ 532.50